Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composite preparation for treating chronic glomerulitis

A technology of glomerulitis and compound preparations, applied in the direction of medical preparations containing active ingredients, drug combinations, organic active ingredients, etc., can solve the problems of inability to treat patients with chronic kidney disease and uncontrolled active disease, To achieve the effect of non-toxic side effects, quick onset, easy to carry and take

Inactive Publication Date: 2017-05-17
ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The former type mainly protects the local damage of the kidney, and cannot treat the clinical manifestations of patients with chronic kidney disease; the latter type has a certain effect on the clinical manifestations of patients with chronic kidney disease, but the local pathological changes of chronic kidney disease are mostly Active lesions coexist with static lesions, and the active lesions become uncontrollable. Although the clinical manifestation is a chronic process, the lesions of the kidney itself will progress progressively until it develops into uremia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A compound preparation for treating chronic glomerulitis, the main raw materials in parts by weight are: 18 parts of Imperata rhizome, 5 parts of madder, 8 parts of kronosin, 5 parts of nordihydrocapsaicin, 4 parts of thiocolchicoside, 2 parts of succinylcholine chloride, 2 parts of menthol, 7 parts of calcium pantothenate, 5 parts of methyl berberine.

[0016] A preparation method for a compound preparation for treating chronic glomerulitis, the specific steps are:

[0017] Firstly, in the pharmaceutical-grade clean area, according to the above metering ratio, weigh Imperata root, madder, kronosin, nordihydrocapsaicin, thiocolchicoside, succinylcholine chloride, menthol, calcium pantothenate, methyl berberine Alkali, sieve, mechanically mix, add ultrapure water, place in a pharmaceutical mixer, mix for 4 minutes, control RSD ≤ 5%, after mixing, press into tablets and dry at low temperature, the temperature is controlled at 4 ° C, and the package is ready to treat chron...

Embodiment 2

[0019] A compound preparation for treating chronic glomerulitis, the main raw materials in parts by weight are: 21 parts of Imperata rhizome, 8 parts of madder, 9 parts of kronosin, 7 parts of nordihydrocapsaicin, 4 parts of thiocolchicoside, 2 parts of succinylcholine chloride, 2 parts of menthol, 8 parts of calcium pantothenate, 9 parts of methyl berberine.

[0020] A preparation method for a compound preparation for treating chronic glomerulitis, the specific steps are:

[0021] Firstly, in the pharmaceutical-grade clean area, according to the above metering ratio, weigh Imperata root, madder, kronosin, nordihydrocapsaicin, thiocolchicoside, succinylcholine chloride, menthol, calcium pantothenate, methyl berberine Alkali, sieve, mechanically mix, add ultrapure water, place in a pharmaceutical mixer, mix for 4 minutes, control RSD ≤ 5%, after mixing, press into tablets and dry at low temperature, the temperature is controlled at 4 ° C, and the package is ready to treat chron...

Embodiment 3

[0023] A compound preparation for treating chronic glomerulitis, the main raw materials in parts by weight are: 25 parts of Imperata rhizome, 10 parts of madder, 10 parts of kronosin, 9 parts of nordihydrocapsaicin, 6 parts of thiocolchicoside, 4 parts of succinylcholine chloride, 5 parts of menthol, 10 parts of calcium pantothenate, 12 parts of methyl berberine.

[0024] A preparation method for a compound preparation for treating chronic glomerulitis, the specific steps are:

[0025] Firstly, in the pharmaceutical-grade clean area, according to the above metering ratio, weigh Imperata root, madder, kronosin, nordihydrocapsaicin, thiocolchicoside, succinylcholine chloride, menthol, calcium pantothenate, methyl berberine Alkali, sieve, mechanically mix, add ultrapure water, place in a pharmaceutical mixer, mix for 6 minutes, control RSD ≤ 5%, after mixing, press into tablets and dry at low temperature, the temperature is controlled at 6°C, and the package is ready to treat chr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composite preparation for treating chronic glomerulitis; the composite preparation for treating chronic glomerulitis is mainly prepared from, by weight, 18-30 parts of lalang grass rhizome, 5-15 parts of radix rubiae, 8-12 parts of coryxine, 5-12 parts of Nordihydrocapsaicin, 4-8 parts of Thiocolchicoside, 2-6 parts of succinylcholine chloride, 2-8 parts of menthol, 7-14 parts of calcium pantothenate, and 5-18 parts of methyl coptisine. The drug selects raw material components strictly according to the knowledge mechanism of chronic glomerulitis, thereby reaching the purpose of comprehensive recovery; the composite preparation is featured by being quick in effect, stable in effect, convenient to carry and use, and free from toxic and side effect after taking for a long time.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a compound preparation for treating chronic glomerulitis. Background technique [0002] Chronic glomerulonephritis (chronic glomerulonephritis), referred to as chronic nephritis, refers to the basic clinical manifestations of proteinuria, hematuria, hypertension, and edema, with different onset patterns, protracted disease, and slow progression of disease, resulting in varying degrees of renal function. A group of glomerular diseases that decline and eventually develop into chronic renal failure. Due to the different pathological types and stages of diseases in this group, the main clinical manifestations are different, and the disease manifestations are diverse. The Chinese patent medicines currently clinically used for the treatment of chronic glomerulonephritis are divided into two categories: one is a monomer component such as Cordyceps sinensis mycelia preparation; the o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P13/12A61K31/437A61K31/165A61K31/704A61K31/225A61K31/045A61K31/197A61K31/4375
CPCA61K36/899A61K31/045A61K31/165A61K31/197A61K31/225A61K31/437A61K31/4375A61K31/704A61K36/74
Inventor 不公告发明人
Owner ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com